MyAverix Finance
SA · Healthcare
Quest Diagnostics Incorporated (Q1UE34)
Diagnostics & Research
Quest Diagnostics Incorporated (Q1UE34) is listed on SA in the Healthcare sector. Industry: Diagnostics & Research. As of 2026-03-29, reported market cap is $116.32B, P/E ratio is 23.10, net margin is 9.0%. Use this page for a quick overview, then open the MyAverix Finance app for income statements, balance sheet, cash flow, and news.
Key metrics for Q1UE34
Quest Diagnostics Incorporated (Q1UE34) — FAQ
What is Quest Diagnostics Incorporated's market cap?
Quest Diagnostics Incorporated (Q1UE34) has a reported market cap of $116.32B (data as of 2026-03-29).
What is Q1UE34's P/E ratio?
The price-to-earnings (P/E) ratio for Quest Diagnostics Incorporated (Q1UE34) is 23.10 (data as of 2026-03-29).
Does Quest Diagnostics Incorporated pay a dividend?
Dividend yield is not available in the current snapshot for Quest Diagnostics Incorporated (Q1UE34). Check the MyAverix Finance app for the latest dividend data.
What sector is Quest Diagnostics Incorporated in?
Quest Diagnostics Incorporated (Q1UE34) is classified in the Healthcare sector (Diagnostics & Research industry).
What exchange is Q1UE34 listed on?
Q1UE34 is listed on SA.
What is Quest Diagnostics Incorporated's net margin?
Quest Diagnostics Incorporated (Q1UE34) reports a net margin of 9.0% (data as of 2026-03-29).
Full report in the app
Get the full report in the MyAverix Finance app — income, balance sheet, cash flow, ratios, and multi-year trends in one place.